The SQUEEZE project will help with the optimization of existing treatments for Rheumatoid Arthritis (RA) by exploring the latest developments in the field of biomarkers. We are focusing on the effect and safety of medicines, and analyse the best implementation science to enhance the therapeutic relationship between patients and doctors.

Welcome to the SQUEEZE Project

Rheumatoid arthritis (RA) is a chronic immune-mediated condition with enormous socioeconomic and individual impact. Despite the availability of various treatment options, every patient seems to respond differently. ​Furthermore, the unsuccessful choice of the most suitable medication for a particular patient can lead to a scenario in which the patient consumes a drug that doesn’t align with their body’s response, ultimately aggravating the patient’s condition. We, at SQUEEZE, in synergy with other EU-wide activities, work to validate clinical, laboratory, molecular, digital, and behavioural biomarkers to help tailor the best treatment to the individual patient.Our aim is to improve the efficacy, safety, and satisfaction with existing therapies (by squeezing the most out of them!).



€ 12.5 Mio

5 years


We are a team of leading academic centres with a first-class record in translational and clinical research, patient research partners and small and medium sized enterprises (SME) active in the field of innovative digital healthcare products, science communication, and project management.

SQUEEZE project

We aim to have a real impact on the life of people with rheumatoid arthritis


SQUEEZE featured in Trend magazine

September 21st, 2023|

Our SQUEEZE project and coordinator Daniel Aletaha have been showcased in the Austrian magazine Trend! 👏 The article spotlights EU-funded initiatives in Austria and highlights the European Union's substantial commitment to research via the [...]

1st issue of our SQUEEZE newsletter published

July 6th, 2023|

We published the 1st issue of our SQUEEZE newsletter on our Linkedin channel!! 🗞️💊 On a bi-annual basis, we will publish insights into our daily collaboration within our 13 partners Horizon Europe funded project. [...]